 |
RPS AdenoPlus™
AdenoPlus is FDA-cleared and is the first CLIA-waived point of care test available for conjunctivitis. It provides a definitive result in 10 minutes and essentially makes available an accurate confirmation of adenoviral conjunctivitis at the time of the exam. AdenoPlus can aid healthcare providers to make an accurate diagnosis, foster patient acceptance of more supportive therapies, identify contagious viral conjunctivitis, and limit the spread of disease.
|
- Product Overview
-